Among different kinases known to be overexpressed in cancer, Mer‐tyrosine kinase (MERTK) belonging to the AXL, TYRO3, and MERTK (TAM) family is an attractive drug target as it is not only involved in cancer cell survival and proliferation but at the same time also regulates the immune responses in cancer (Lahey et al. 2022). This evidence concerns the gene STIM1 and cancer.